UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000023125
Receipt No. R000026656
Official scientific title of the study Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma
Date of disclosure of the study information 2016/07/12
Last modified on 2016/07/12 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma
Title of the study (Brief title) Risk factors for latent distant organ metastasis in patients with locally advanced pancreatic ductal adenocarcinoma
Region
Japan

Condition
Condition data collected
Classification by specialty
Hepato-biliary-pancreatic surgery Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To identify risk factors for latent distant organ metastasis in patients with radiographically defined locally advanced (RDLA) pancreatic ductal adenocarcinoma (PDAC).
Basic objectives2 Others
Basic objectives -Others morbidity of latent distant organ metastasis in patients with RDLA-PDAC
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Risk factors for latent distant organ metastasis in patients with radiographically defined locally advanced (RDLA) pancreatic ductal adenocarcinoma (PDAC).
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria radiographycally-defined locally advanced PDAC
Key exclusion criteria Patients who denied staging laparoscopy
Target sample size 110

Research contact person
Name of lead principal investigator Sohei SATOI MD, FACS
Organization Kansai Medical University
Division name Surgery
Address 2-5-1, Shin-machi, Hirakata OSAKA, JAPAN
TEL +81-72-804-0101
Email satoi@hirakata.kmu.ac.jp

Public contact
Name of contact person Sohei SATOI MD, FACS
Organization Kansai Medical University
Division name Surgery
Address 2-5-1, Shin-machi, Hirakata OSAKA, JAPAN
TEL +81-72-804-0101
Homepage URL
Email satoi@hirakata.kmu.ac.jp

Sponsor
Institute Kansai medical university
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 12 Day

Progress
Recruitment status Completed
Date of protocol fixation
2005 Year 01 Month 01 Day
Anticipated trial start date
2005 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information The presence or not of minute distant organmetastasis using staging laparoscopy in patients with RDLA-PDAC

Management information
Registered date
2016 Year 07 Month 12 Day
Last modified on
2016 Year 07 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026656